Mo1464 The Results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis With Risperidone-2 (Tokyo P3R-2): a Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial

  • Rie Uchino, Hiroyuki Isayama, Takeshi Tsujino, Yukiko Ito, Saburo Matsubara, Naminatsu Takahara, Toshihiko Arizumi, Nobuo Toda, Dai Mohri, Osamu Togawa, Hiroshi Yagioka, Dai Akiyama, Tsuyoshi Hamada, Koji Miyabayashi, Suguru Mizuno, Kazumichi Kawakubo, Hirofumi Kogure, Takashi Sasaki, Natsuyo Yamamoto, Yousuke Nakai, Naoki Sasahira, Kenji Hirano, Minoru Tada, Kazuhiko Koike
  • Gastrointestinal Endoscopy, May 2013, Elsevier
  • DOI: 10.1016/j.gie.2013.03.212

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.gie.2013.03.212

The following have contributed to this page: Dr Yousuke Nakai